12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 404 Not Found [1] => Date: Wed, 14 Oct 2026 21:23:44 GMT [2] => Content-Type: text/html; charset=iso-8859-1 [3] => Connection: close [4] => x-frame-options: SAMEORIGIN [5] => x-content-type-options: nosniff [6] => x-xss-protection: 1; mode=block [7] => referrer-policy: strict-origin-when-cross-origin [8] => permissions-policy: geolocation=(), microphone=(), camera=() [9] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [10] => Server: cloudflare [11] => strict-transport-security: max-age=31536000; includeSubDomains; preload [12] => cf-cache-status: DYNAMIC [13] => Speculation-Rules: "/cdn-cgi/speculation" [14] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [15] => Server-Timing: cfEdge;dur=15,cfOrigin;dur=10 [16] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=N%2B5CmsbjZ1vbMPaoewOMRSJN284VvzTEGO3IW23SlZ8MNrXQ13oCeQ1ocXBhCqa4PmmFHW2CFBg9BtlLXlUvIz0GR5E9%2FW6QCcKQs8OWgdjWM4k5UxmWMC%2BqHE0nLBrJWzU%3D"}]} [17] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [18] => CF-RAY: a4a9a598bc4e8325-SIN [19] => alt-svc: h3=":443"; ma=86400 ) 789

针对新加坡科学局宣布召回3种含有超标致癌物质的药物二甲双胍（metformin），我国卫生部周四发文告强调，我国并没批准发售这3种药物。

这3种药物包括Glucient XR Tablet 500mg、Meijumet Prolonged Release Tablet 750mg，以及Meijumet Prolonged Release Tablet 1000mg；有关药物是控制血糖的药物。

卫生总监拿督诺希山周四在文告中指出，卫生部对国家药品监管局（NPRA）注册的药物进行审查后发现，美国药物管制局共检验101项药物含有二甲双胍成份，然而只有获得注册的药物才获准在我国发售。

文告指，NDMA是亚硝胺基的杂质之一，通常含量较低。“根据国际癌症研究机构（IARC）显示，长期服用NDMA将增加患癌风险。”

“二甲双胍是一种治疗糖尿病以控制血糖的药物，平时可从医生或药剂师处获取。”

无论如何，国家药品监管局将继续监视市面上的药物，确保药物的质量、安全和有效性，并随时提醒民众。